Literature DB >> 20413216

Epidermal growth factor-induced epithelial-mesenchymal transition in human esophageal carcinoma cells--a model for the study of metastasis.

Zhen Cai1, Qian Wang, Yuan Zhou, Lei Zheng, Jen-Fu Chiu, Qing-Yu He.   

Abstract

Deciphering the molecular basis of esophageal cancer metastasis requires adequate experimental models. Epithelial-mesenchymal transition (EMT) is the hallmark of tumor metastasis. As a promoter of the malignant progression of esophageal cancer, epidermal growth factor (EGF) has been shown to induce EMT in several cell lines. In this study we examined the effects of EGF on esophageal carcinoma EC109 cells. We found that EGF at high concentration induced the cells to undergo morphological change, exhibit higher invasive and metastatic potential, as well as change in the expression of lineage markers. This EMT model might facilitate mechanistic studies of esophageal cancer metastasis. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20413216     DOI: 10.1016/j.canlet.2010.03.020

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  TRPM8 promotes aggressiveness of breast cancer cells by regulating EMT via activating AKT/GSK-3β pathway.

Authors:  Jinxin Liu; Yizhi Chen; Shuai Shuai; Dapeng Ding; Rong Li; Rongcheng Luo
Journal:  Tumour Biol       Date:  2014-06-06

2.  Hepatic stellate cells secretes type I collagen to trigger epithelial mesenchymal transition of hepatoma cells.

Authors:  Ming-Chen Yang; Chih-Jung Wang; Pao-Chi Liao; Chia-Jui Yen; Yan-Shen Shan
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

3.  Specific N-glycan alterations are coupled in EMT induced by different density cultivation of MCF 10A epithelial cells.

Authors:  Qingsong Xu; Xueming Niu; Wenjing Wang; Wen Yang; Yuguang Du; Jianguo Gu; Linsheng Song
Journal:  Glycoconj J       Date:  2016-12-29       Impact factor: 2.916

4.  Role of a Disease-associated ST3Gal-4 in Non-small Cell Lung Cancer.

Authors:  Praveen Singh; Archana Joon; Munmun Kumari; Tanya Singh; Amanjit Bal; Pratibha Maan; Sujata Ghosh
Journal:  Cell Biochem Biophys       Date:  2022-09-09       Impact factor: 2.989

5.  Andrographis paniculata elicits anti-invasion activities by suppressing TM4SF3 gene expression and by anoikis-sensitization in esophageal cancer cells.

Authors:  Grace Gar-Lee Yue; Julia Kin-Ming Lee; Lin Li; Kar-Man Chan; Eric Chun-Wai Wong; Judy Yuet-Wah Chan; Kwok-Pui Fung; Vivian Wai Yan Lui; Philip Wai-Yan Chiu; Clara Bik-San Lau
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

6.  Metformin: an emerging new therapeutic option for targeting cancer stem cells and metastasis.

Authors:  Ramandeep Rattan; Rouba Ali Fehmi; Adnan Munkarah
Journal:  J Oncol       Date:  2012-06-04       Impact factor: 4.375

7.  Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT.

Authors:  Xinsheng Peng; Wei Guo; Tiejian Liu; Xi Wang; Xiang'an Tu; Dafu Xiong; Song Chen; Yingrong Lai; Hong Du; Guangfu Chen; Guanglin Liu; Yubo Tang; Shuai Huang; Xuenong Zou
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

8.  MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.

Authors:  Qiang Han; Hua-Yong Zhang; Bei-Long Zhong; Xiao-Jing Wang; Bing Zhang; Hua Chen
Journal:  Med Sci Monit       Date:  2016-10-23

9.  Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1.

Authors:  Byong-Ki Cha; Young-Suk Kim; Ki-Eun Hwang; Kyung-Hwa Cho; Seon-Hee Oh; Byoung-Ryun Kim; Hong-Young Jun; Kwon-Ha Yoon; Eun-Taik Jeong; Hak-Ryul Kim
Journal:  Oncotarget       Date:  2016-08-30

10.  Low disabled-2 expression promotes tumor progression and determines poor survival and high recurrence of esophageal squamous cell carcinoma.

Authors:  Wen-Lun Wang; Wei-Lun Chang; Hsiao-Bai Yang; Yu-Chi Wang; I-Wei Chang; Ching-Tai Lee; Chi-Yang Chang; Jaw-Town Lin; Bor-Shyang Sheu
Journal:  Oncotarget       Date:  2016-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.